What content must be CDISC CDASH Compliant?
All CTEP IND studies activated after 1/1/2020 shall be CDISC compliant.
What content must be CDISC SDTM compliant?
- While not all data collected will need to be reported (e.g. safety data), all reported content as defined by the FDA submission standard must be compliant.
What actions are needed (from an NCI perspective) if a Common Data Element (CDE) is not required by CDISC?
- If the CDE is not a required CDISC standard and is needed in your study, submit the request to the NCI CDISC Harmonization WG (ncicdiscsupport@nih.gov) for consideration as a CDISC standard.
What actions are needed to make a partial match CDE compliant with CDISC CDASH requirements?
- Use the CDISC CDASH and SDTM supplemental guides to create a new CDISC CDASH compliant CDE.
What fields need to match for a CDE to be CDISC CDASH compliant?
- All fields should match all CDISC variables to minimize compliance issues during submission.
Does a CDE with no match to CDISC CDASH/ SDTM require manual creation based on the CDISC CDASH/ SDTM guides?
Yes; create a new CDE that matches the CDISC CDASH requirements. Contact the CBIIT caDSR Team to create a new CDE.
- What about the CDISC standards that are not geared towards oncology trials?
CDISC has developed 4 Oncology Standards: Breast, Prostate, Colorectal and Lung. NCI can propose additional domains as needed.
What is the burden of CDISC compliance on legacy trials?
Legacy Trials are not impacted by the CDISC Implementation
What is the burden of CDISC compliance on new trials?
NCI will follow FDA requirements. Any required data being reported to the FDA for new trials needs to be CDISC compliant.
How are potential differences between CDUS Complete reporting versus CDASH requirements to be managed?
NCI is aware of the various reporting requirements and these will be addressed during impact analysis and implementation activities.
Topic# | Question/ITEM | Response |
1 | What content must be CDISC CDASH compliant? | Initially, collected content that is part of a CTEP |
2 | What content must be CDISC SDTM compliant? | While not all data collected will need to be reported |
3 | What actions are needed (from an NCI perspective) if a Common | Leave CDE "as is"; submit a request/ |
4 | What actions are needed to make a 'partial match' CDE | Use the CDISC CDASH and SDTM guides to create a new CDISC |
5 | What fields need to | All fields should match all CDISC variables to minimize |
6 | Does a CDE with no match to CDISC CDASH/ SDTM require | Yes; create a new CDE that matches the CDISC CDASH |
7 | What about the CDISC standards that are not geared towards | CDISC has developed 4 Oncology Standards: Breast, Prostate, Colorectal and Lung. NCI can propose additional domains as |
8 | What is the burden of CDISC compliance on legacy trials? | This does not |
9 | What is the burden of CDISC compliance on new trials? | NCI will follow FDA requirements. Any required data being reported to the FDA |
10 | What is the potential impact to existing systems? | Unknown presently, NCI will be performing an Impact Analysis |
11 | How are potential differences between CDUS Complete | NCI is aware of the various reporting requirements and |
Workflows